...
机译:P2.01-004 NSCLC患者VS良性肿瘤患者血浆无细胞DNA中多肿瘤抑制基因的甲基化分析
Genetics and Clinical Immunology National Institute of Tuberculosis and Lung Diseases;
Genetics and Clinical Immunology National Institute of Tuberculosis and Lung Diseases;
Department of Medical Genetics National Research Institute of Mother and Child;
Department of Pathomorphology National Institute of Tuberculosis and Lung Diseases;
Genetics and Clinical Immunology National Institute of Tuberculosis and Lung Diseases;
Department of Medical Genetics National Research Institute of Mother and Child;
Department of Pathomorphology National Institute of Tuberculosis and Lung Diseases;
Department of Thoracic Surgery National Institute of Tuberculosis and Lung Diseases;
Department of Thoracic Surgery National Institute of Tuberculosis and Lung Diseases;
Iii Department of Lung Diseases National Institute of Tuberculosis and Lung Diseases;
Department of Thoracic Surgery National Institute of Tuberculosis and Lung Diseases;
Iii Department of Lung Diseases National Institute of Tuberculosis and Lung Diseases;
Genetics and Clinical Immunology National Institute of Tuberculosis and Lung Diseases;
机译:P2.01-004 NSCLC患者VS良性肿瘤患者血浆无细胞DNA中多肿瘤抑制基因的甲基化分析
机译:血浆细胞无细胞DNA甲基化联合肿瘤突变检测在非小细胞肺癌(NSCLC)患者的预后预测中
机译:少突胶质细胞瘤中抑癌基因的甲基化谱和临床结果
机译:估计良性肿瘤患者辐射污染区不同〜(137)铯密度估算患者
机译:人类癌症中肿瘤抑制基因的异常表观遗传沉默:DNA高度甲基化和组蛋白密码的作用。
机译:少突胶质细胞瘤中抑癌基因的甲基化谱和临床结果
机译:评估肿瘤抑制基因的甲基化状态和扩增癌基因,如肺癌患者无血浆DNa中的分子标记,在波哥大的四家医院进行治疗 - 哥伦比亚/评估肿瘤抑制基因的甲基化状态和扩增癌基因,作为肺癌患者血浆游离DNa的分子标志物,在波哥大 - 哥伦比亚的四家医院接受治疗。